For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products for…

Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…

Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy Again…
Search Posts
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products for…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy Again…
Blog
CBO likely overestimates effects of Medicaid reforms
Yesterday, the Congressional Budget Office (CBO) released its estimates of the costs, both financial and in coverage, of the One Big Beautiful Bill Act…
Blog
Don’t socialize health care through private insurance
Four senators have introduced the “Supporting Healthy Moms and Babies Act,” which would mandate full coverage, no copays, no out-of-pocket costs for beneficiaries…
Blog
Medicaid cost explosion
Over the past five years, Medicaid has defied all expectations and projections. It is the third largest program that the government administers, and it has…
Blog
Big Beautiful Bill threatens the Costco of health care
You’ve probably never wondered why you buy peanut butter from the grocery store instead of directly from the J.M. Smucker Company or your TV from…
News Release
MAHA Commission recommendations on improving government-directed research merit consideration
President Trump’s Make America Healthy Again Commission released the “Making Our Children Health Again” report, which seeks to evaluate health trends among America’s youth,…
Blog
States can keep Medicaid whole if they want
Congress is considering slowing Medicaid growth over the next 10 years enough to reduce federal spending by $625 billion. Many Republicans argue that the…
The Washington Examiner
Capping drug prices will cripple innovation and harm public health
The Washington Examiner cited CEI’s expert on life-saving drugs and technology The Competitive Enterprise Institute was similarly scathing. “As with many industries, the United States…
Blog
Free the Economy podcast: Reforming Medicaid with Brian Blase
In a recent episode we cover biofuels and farm tariffs, the decline in green investing, and the effort to stop state governments…
The Epoch Times
What to Know About Trump’s Plan to Slash Drug Prices
The Epoch Times cited CEI’s expert on drug prices “Jeremy Nighohossian, a senior fellow at the Competitive Enterprise Institute, a libertarian think tank, told The…
Blog
GOP proposal includes reductions in health care expenditures
Over the weekend the House Committee on Energy and Commerce released a proposal describing how it would achieve the expenditure goals for the Reconciliation…
Blog
The numbers don’t add up in new Medicaid paper
In a recently released working paper, authors Angela Wyse and Bruce D. Meyer purport to show that the ACA Medicaid expansion saved 27,400 lives…
Letters
CEI joins ATR Coalition Urging CRA on Medical Debt Rule
Dear Member of Congress, We are writing to express our concerns regarding the Consumer Financial Protection Bureau’s finalized rule on eliminating medical debt records from…
Blog
FTC’s second interim report on PBMs: Don’t hold your breath
The Federal Trade Commission (FTC) will consider issuing a second interim report on Pharmacy Benefit Managers (PBMs) tomorrow during its January 14 open meeting.
Blog
Congress shouldn’t rely on incomplete FTC PBM study
Lawmakers are making a last-minute push to regulate the practices of pharmacy benefit managers (PBMs) during the lame duck session. However, it would be a…
Wall Street Journal
A Thumb on the Scale for Wegovy
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Study
Evaluating Telehealth
Executive Summary Why Did We Write This Report Telehealth—the use of remote audio and/or video technologies to provide health care services—has been promoted as…
News Release
Report: Telehealth flexibility deadline looms, but Congress needs better information to decide
Congress is poised to consider proposals that permanently or temporarily extend flexibilities for telehealth services enacted during the COVID-19 pandemic that are set to expire…
Blog
This week in ridiculous regulations: Human subjects and food paper
Republicans called Puerto Rico a “floating island of garbage” as a voter outreach tactic. Democrats got upset that a newspaper that generally supports Democrats didn’t endorse…
The Washington Post
What Trump winning the election could mean for the CDC
The Washington Post cites CEI expert Joel Zinberg on the changing face of the CDC and what does (and doesn’t) belong in the agency: “Many…
CSPAN
VIDEO: Dr. Joel Zinberg joins CSPAN to discuss health care proposals from presidential candidates
Click here to read more.
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
Blog
Free the Economy podcast: Reforming red tape in the states with James Broughel
In this week’s episode we cover striking dock workers at US ports, free-market innovation in healthcare, and the changing pattern of federal…
Blog
Adam Smith on health policy
Today the Competitive Enterprise Institute published my OnPoint essay, “The Innovation Imperative: What Adam Smith Can Tell Us About Health.” This was adapted from…
News Release
Report: Health gains stem from private sector innovation, not government
A new Competitive Enterprise Institute report delves into evidence that populations are healthier and live longer as the result of private sector, profit-driven innovations…
Study
The Innovation Imperative
The Competitive Enterprise Institute recently celebrated its 40th anniversary in Edinburgh, Scotland. Edinburgh was chosen because the city was celebrating the 300th anniversary of the…
HeartLand Daily News
FDA Hid COVID Shot Side Effects—Congressional Report
Heartland Daily News cited CEI on COVID public health concerns Joel Zinberg, M.D., senior fellow at the Competitive Enterprise Institute and director of the Public…
Op-Eds
Often Wrong, Never in Doubt
Times have changed. Two years ago, tennis great Novak Djokovic could not play in the U.S. Open tournament. It was not because he had Covid-19…
Blog
Can AI thrive in health care’s HIPAA-shaped box?
Innovation continues to transform health care, enabling us to live longer and healthier lives. And now artificial intelligence (AI) is poised to supercharge that…
The Wall Street Journal
The FTC Goes Evidence-Free
Through three years of Lina Khan’s leadership, the Federal Trade Commission has suffered an unprecedented streak of high-profile court defeats. That’s because the agency regularly makes…
Blog
This week in ridiculous regulations: Blood donors and paper marketing
Donald Trump survived an assassination attempt. The Republicans held their convention in Milwaukee. Sen. Robert Menendez (D-NJ) was convicted on bribery charges and resigned, leaving…
Blog
Missing the economists in FTC’s latest PBM study
The Federal Trade Commission (FTC) released its not-so-objectively titled interim report on Pharmacy Benefit Managers (PBMs): Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug…
News Release
New FTC study on drug costs fails to conduct empirical analysis of market conditions
The Federal Trade Commission (FTC) release a new study today claiming Pharmacy Benefit Managers (PBMs) are responsible for higher drug costs. FTC Commissioner Melissa Holyoak…
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Blog
This week in ridiculous regulations: Taconite and lab fees
President Biden delivered his State of the Union address. Super Tuesday primaries all but settled this year’s presidential combatants. The FTC has a full slate…
National Review
Covid Vaccines: An Update on Balancing Risks and Benefits
A new large, multi-country study has confirmed what previous smaller studies found: Covid-19 vaccines have risks. In particular, the messenger RNA (mRNA) vaccines from Pfizer and…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
The Federalist Society
Explainer 62 – FDA’s Regulation of Laboratory Developed Tests
CEI’s Joel Zinberg joined a podcast hosted by The Federalist Society for the Regulatory Transparency Project on the FDA’s regulation of laboratory developed tests:…
National Review
When Science Is Not Science
Just 22 percent of all adults and 41 percent of those 65 and older — the most vulnerable group — have received the updated 2023–24 Covid-19 vaccine.
Blog
When the FTC’s anti-merger goals overshadow the prospect of saving lives
The Fifth Circuit Court of Appeals recently issued a ruling on the important case of Illumina-Grail v. Federal Trade Commission. A unanimous 3-0…
Beritbart
Unholy Alliance Between the Left and Big Pharma Threatens More Big Government Intervention in Health Care
CEI’s Joel Zinberg is cited in Breitbart on the big government intervention in healthcare: Economic experts recognize that the very foundation of a free…
City Journal
A “Coordinated Campaign”
The Covid-19 pandemic revealed a split between those who believe that the government has broad authority to control every aspect of the economy and society…
Washington Times
Cutting-edge drugs could vanish under Biden’s unprecedented move to seize patents
CEI’s Dr. Joel Zinberg is cited in the Washington Times on the Biden Administration’s move to seize patents: Dr. Joel Zinberg, a senior fellow…
National Review
Another FDA Power Grab
The comment period for the Food and Drug Administration’s latest power grab has just concluded. Roughly 20,000 comments were submitted addressing the FDA’s proposed rule which…
Comment
Comments RE: Docket No. FDA–2023–N–2177 for “Medical Devices; Laboratory Developed Tests
I am an attorney with the Competitive Enterprise Institute. The Competitive Enterprise Institute is a non-profit research and advocacy organization that focuses on regulatory policy.
Washington Times
Better late than never: New York Times finally admits school shutdowns hurt children
The New York Times has made a “startling” discovery. Its editorial board has recognized that “school closures that took 50 million children out of classrooms…
City Journal
Not-So-Affordable Care
In a 2022 book, Seemed Like a Good Idea, health economist Mark Pauly and his University of Pennsylvania coauthors describe how health-care policymakers “often rely on…
News Release
CEI leads coalition calling on Congress to repeal drug price control provisions of the Inflation Reduction Act
The Competitive Enterprise Institute (CEI) and a coalition 43 conservative and free market groups sent a letter to Congress today calling for the…
Letters
Coalition Letter to End IRA Prescription Drug Price Controls
October 31, 2023 Dear Members of Congress, When the Inflation Reduction Act was passed and signed into law a year ago, the legislation granted the…
Blog
This week in ridiculous regulations: Blood donations to mortality tables
Poland voted its nationalist-populist government out of power. The US House of Representatives remained without a speaker, but with a lot of drama. Agencies issued…
City Journal
Equity vs. Evidence
The U.S. Preventive Services Task Force—a volunteer panel of national experts in prevention and evidence-based medicine that makes recommendations for clinical preventive services such as…
National Review
Restricting Pharmacy Benefit Managers Could Decrease Competition and Increase Drug Costs
Congress is considering multiple bills that aim to restrict the ability of pharmacy benefit managers (PBMs) to negotiate discounts and rebates and to require the PBMs…
PCMA
Just the Facts: Research and Analysis Finds Anti-PBM Legislation Does Not Lower Prescription Drug Costs for Patients
PCMA cites CEI’s Joel Zinberg anti PBM legislation: “This policy would significantly change drug pricing and utilization and shift billions of dollars annually from patients…
Wall Street Journal
Court to FDA: Stop Playing Doctor
The Food and Drug Administration regulates pharmaceuticals, but it has no business playing doctor and giving you medical advice. That’s the message of a Sept.
News Release
Congressional Efforts to Regulate PBMs Risk Higher Drug Costs, Worse Health Outcomes for Patients
Pharmacy Benefit Managers (PBMs) are private businesses that developed in the free market to manage prescription drug benefits for health insurance plan sponsors. Nearly all…
Study
A Free Market Solution for Drug Distribution
Executive summary This paper describes and explains the function of Pharmacy Benefit Managers (PBMs) in the American health care economy. PBMs are private businesses that…
New York Post
Djokovic can compete in the US Open again — after Biden finally ended his unscientific travel ban
The US Open tennis tournament has begun in Queens, and one of the world’s best players will finally be allowed to compete again. Novak…
New York Post
Don’t believe doomsayers — new COVID outbreak is mild, and masks don’t help
COVID-19 cases are expected to rise this fall as new variants become more prevalent. And, as unfortunately expected, it’s already triggered demands by…
Fox News
New report reveals how CDC can be ready for the next pandemic
The Centers for Disease Control and Prevention has a new director, Dr. Mandy Cohen. Her predecessor, Dr. Rochelle Walensky, acknowledged CDC was…
Citation
Dr. Joel Zinberg discusses his report on refocusing and reforming the CDC after COVID-19 on C-SPAN’s Washington Journal
CEI Senior Fellow Joel Zinberg joined Washington Journal on August 11, 2023 to discuss new study from CEI and Paragon Health Institute which found…
News Release
New Study from CEI and Paragon Health Institute finds CDC shortcomings and recommends key reforms
The Competitive Enterprise Institute (CEI) and the Paragon Health Institute published a new paper today by CEI senior fellow and director of…
Study
Unauthorized and Unprepared: Refocusing the CDC after COVID-19
Executive Summary What This Paper Covers The Centers for Disease Control and Prevention, the nation’s preeminent public health agency, has acknowledged that it failed badly…
Blog
This week in ridiculous regulations: soybean standards and pain medication limits
The FTC issued its new draft merger guidelines. Meanwhile, agencies issued new regulations ranging from milk marketing to Postal Service snitches. On to the…
New York Post
Memo to critics: Only folks who don’t qualify will lose their Medicaid
Medicaid advocates are demanding the federal government to stop states from removing people from the program after 25 states and the District of Columbia dropped…
City Journal
Lab Leak: Likely
Three previously unreleased State Department cables, obtained by the public-health group U.S. Right to Know through a Freedom of Information Act lawsuit, confirm…
Washington Examiner
The Biden administration shouldn’t waste more taxpayer dollars on COVID vaccines
A Food and Drug Administration advisory committee recently voted to recommend updating the COVID-19 vaccine. But important questions remain: When…
Letters
CEI Joins Coalition Letter Supporting Efforts to Stop Tobacco Prohibitions in Ag Approps Bill
Chairwoman Granger and Ranking Member DeLauro, The undersigned organizations representing millions of consumers and taxpayers support Sections 768 and 769 of the Fiscal Year 2024…
National Review
Pharmaceuticals: Marching into Trouble
The National Institutes of Health recently rejected a request by private petitioners to exercise “march-in rights” under the 1980 Bayh-Dole Act to control the…
City Journal
Nature’s Vaccine
Public-health officials in the U.S., unlike their counterparts elsewhere, have steadfastly focused on Covid-19 vaccines in fighting the pandemic, acting as if natural immunity following…
Washington Examiner
Under Walensky, the CDC has destroyed public trust in its credibility
The White House announced last week that Dr. Rochelle Walensky will be leaving her post as director of the Centers for Disease Control and Prevention. She…
Wall Street Journal
Don’t Let Unspent Covid Funds Become Slush Funds
The House has passed the Limit, Save, Grow Act, which would raise the debt limit for a year in exchange for deficit-relief measures. One of…
National Review
No, Lockdown States Did Not Do Better
Many politicians, public-health figures, and media pundits continue to insist that the Covid lockdowns were a success and represent a blueprint for future pandemic responses. Illinois…
City Journal
Roll It Back
Medicaid, the federal-state entitlement for the poor, now provides health insurance to more than one in four Americans. Enrollments surged after the Affordable Care Act…
City Journal
Politically Correct Medical Scholarship Doesn’t Help Blacks
A recent article in the British Medical Journal, “Inequities in surgical outcomes by race and sex in the United States,” is important—not…
National Review
Was the U.S. furtively funding the lab research that unleashed Covid-19?
Slowly but surely, new cracks are appearing in the wall of silence denying Chinese culpability in causing the nearly 7 million deaths attributed to…
Blog
Covid Lockdowns Did Not Improve Outcomes: Lessons from Florida and California
My Competitive Enterprise Institute colleague Dr. Joel Zinberg is the co-author of a new report, published by the Paragon Health Institute titled “Freedom Wins:…
The Center Square
Fauci takes heat after casting doubt on efficacy of COVID vaccines
CEI’s Joel Zinberg is cited in The Center Square on COVID vaccines: Joel Zinberg, a Competitive Enterprise Institute senior fellow, blasted Fauci for pushing for…
The Washington Journal
VIDEO: Joel Zinberg Joins the Washington Journal
Dr. Joel Zinberg joins the Washington Journal to discuss the efficacy of COVID lockdowns and government restrictions as they relate to public health and take…
The Washington Journal
Video: Dr. Joel Zinberg Joins the Washington Journal to Discuss COVID Lockdowns
Dr. Joel Zinberg joins the Washington Journal to discuss the efficacy of COVID lockdowns and government restrictions as they relate to public health and take…
National Review
Fauci Changes His Public Tune on Covid Vaccines
Dr. Anthony Fauci has finally acknowledged that there had always been good scientific reasons to believe that vaccines against the respiratory…
New York Post
The numbers prove Cuomo’s lockdowns hurt NYers on EVERY metric — while Florida flourished
What a difference a few years make. In 2020, the mainstream media lauded Gov. Andrew Cuomo for his strong but compassionate COVID-19 leadership. He won a…
Fox News
DeSantis’s Florida beats Newsom’s California, again. Here’s the comparison
The COVID-19 pandemic elicited unprecedented government interventions into American life. Yet, the stringency and duration of government measures varied considerably across the U.S. …
Study
Freedom Wins
ABOUT THE AUTHORS Joel M. Zinberg, M.D., J.D. is the Director the Public Health and American Well-Being Initiative at Paragon Health Institute, and a senior…
Blog
Fauci Failure to Acknowledge Limited Vaccine Protection Undermines Faith in Government Advice
In a recent article Dr. Anthony Fauci acknowledged that, from the beginning of the pandemic, there was good reason to believe that vaccines against…
Regulatory Transparency Project
AUDIO: Explainer Episode 48 – The FDA & the Practice of Medicine: Possible Regulation of Off-Label Prescriptions
Senior Fellow Joel Zinberg joins the Regulatory Transparency Project to discuss possibly regulation of off-label prescriptions: On December 29, 2022, President Biden signed the Consolidated Appropriations…
Citation
FDA’s Medical Interference, Time for ESG Antitrust Action and other commentary
Libertarian: FDA’s Medical Interference The Wall Street Journal quoted Joel Zinberg on FDA banning practices: “Secreted within the 2023 omnibus appropriations…
Wall Street Journal
The FDA Wants to Interfere in the Practice of Medicine
Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced. Physicians routinely prescribe…
City Journal
PODCAST: The Last Gasp of Pandemic Restrictions?
Senior Fellow Joel Zinberg joins Brian Anderson at City Journal to discuss the “tripledemic” of Covid, flu and RSV, the relationship of public health and…
Blog
Omnibus Bill Throws More Money at CDC, Does Not Reform It
Congress has passed the $1.7 trillion fiscal 2023 omnibus appropriations bill. The 4,155-page legislation, which covers everything from agriculture to veterans, includes a section…
City Journal
Ignore the “Tripledemic” Hype
Winter is back, and so are warnings from “experts” for Americans to don masks. A resurgence of influenza (flu) and respiratory syncytial virus (RSV)—respiratory illnesses…
National Review
Senate, Forget about Rolling Back the Government Takeover of Health Care
Elections have consequences. Republicans’ failure to capture the U.S. Senate means that the Senate Committee on Health, Education, Labor, and Pensions — known as the HELP…
City Journal
End the Vaccine Mandates
One year ago, the Center for Medicare & Medicaid Services (CMS) issued an interim final rule requiring 15 types of health-care facilities that…